Citation analysis for PharmacoEconomics / Springer

Citation Profile [Updated: 2026-03-14 21:09:38]

5 Years H Index

Impact Factor (IF)

0.08

5 Years IF

0.09

Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw Data

	IF	AIF	CIF	IF5	DOC	CDO	CIT	NCI	CCU	D2Y	C2Y	D5Y	C5Y	SC	%SC	CiY	II	AII
1997	0	0.24	0	0	10	10	17		1	0		0			0		0	0.11
1998	0	0.27	0	0	12	22	8		1	10		10			0		0	0.13
2000	0	0.34	0.03	0.05	9	31	15	1	7	12		22	1		0		0	0.16
2001	0	0.38	0.09	0.1	3	34	4	3	10	9		31	3	2	66.7		0	0.17
2003	0	0.43	0.13	0.13	5	39	13	5	18	3		24	3	1	20		0	0.21
2004	0.2	0.47	0.08	0.12	1	40	3	3	21	5	1	17	2		0		0	0.21
2005	0.17	0.51	0.04	0.06	7	47	14	2	23	6	1	18	1		0		0	0.23
2006	0	0.49	0.17	0.13	62	109	130	18	41	8		16	2	15	83.3	13	0.21	0.22
2007	0.09	0.44	0.08	0.09	38	147	100	12	53	69	6	75	7	5	41.7	2	0.05	0.2
2008	0.07	0.47	0.07	0.08	22	169	301	11	64	100	7	113	9	4	36.4		0	0.22
2009	0.18	0.46	0.11	0.13	28	197	84	22	86	60	11	130	17	8	36.4	1	0.04	0.23
2010	0.44	0.46	0.22	0.27	33	230	79	51	137	50	22	157	42	11	21.6		0	0.2
2011	0.13	0.51	0.18	0.16	32	262	126	46	183	61	8	183	30	16	34.8	5	0.16	0.23
2012	0.42	0.5	0.36	0.39	94	356	191	127	310	65	27	153	59	64	50.4	26	0.28	0.21
2013	0.31	0.54	0.28	0.31	97	453	471	125	435	126	39	209	65	37	29.6	27	0.28	0.24
2014	0.2	0.53	0.21	0.2	111	564	398	118	553	191	39	284	56	29	24.6	18	0.16	0.22
2015	0.31	0.52	0.28	0.28	106	670	387	189	742	208	64	367	103	31	16.4	16	0.15	0.22
2016	0.27	0.5	0.26	0.28	133	803	299	206	948	217	59	440	121	36	17.5	12	0.09	0.2
2017	0.28	0.52	0.28	0.26	116	919	316	254	1203	239	67	541	140	60	23.6	28	0.24	0.21
2018	0.27	0.53	0.29	0.31	128	1047	201	308	1511	249	68	563	177	40	13	12	0.09	0.22
2019	0.29	0.54	0.32	0.27	132	1179	247	377	1888	244	71	594	162	60	15.9	34	0.26	0.21
2020	0.24	0.64	0.33	0.29	118	1297	112	429	2317	260	62	615	181	34	7.9	15	0.13	0.3
2021	0.23	0.74	0.32	0.24	114	1411	99	445	2762	250	58	627	150	38	8.5	18	0.16	0.27
2022	0.23	0.73	0.3	0.27	120	1531	65	463	3225	232	53	608	167	28	6	25	0.21	0.22
2023	0.11	0.69	0.21	0.17	105	1636	41	348	3573	234	25	612	104	24	6.9	16	0.15	0.2
2024	0.16	0.81	0.2	0.16	113	1749	9	356	3929	225	36	589	97	18	5.1	11	0.1	0.23
2025	0.08		0.12	0.09	107	1856	3	216	4145	218	18	570	49	9	4.2	4	0.04

IF:	Two years Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for all series in RePEc in year y
CIF:	Cumulative impact factor
IF5:	Five years Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CIT:	Number of citations to papers published in year y
NCI:	Number of citations in year y
CCU:	Cumulative number of citations to papers published until year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
SC:	selft citations in y to articles published in y-1 plus y-2
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series

#	Year	Title	Cited
1	2013	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers \|\| Download paper	259
2	2008	Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers \|\| Download paper	231
3	2014	Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers \|\| Download paper	103
4	2019	Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Soekhai, Vikas ; Bekker-Grob, Esther W ; Ellis, Alan R. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers \|\| Download paper	90
5	2017	Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers \|\| Download paper	79
6	2016	Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers \|\| Download paper	56
7	2015	The Epidemiology of Obesity: A Big Picture. (2015). Hu, Frank ; Hruby, Adela . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers \|\| Download paper	50
8	2013	How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers \|\| Download paper	40
9	2014	A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers \|\| Download paper	39
10	2016	EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Oppe, Mark ; Rand-Hendriksen, Kim ; Ramosgoi, Juan M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers \|\| Download paper	38
11	2015	The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Seuring, Till ; Archangelidi, Olga. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers \|\| Download paper	37
12		Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers \|\| Download paper	34
13	2014	Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers \|\| Download paper	31
14	2015	Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Meyerhoefer, Chad ; Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers \|\| Download paper	29
15	2017	The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Trapero-Bertran, Marta ; Pea-Longobardo, Luz Maria ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers \|\| Download paper	27
16	2012	Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn ; Woolacott, Nerys ; Bojke, Laura. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270. Full description at Econpapers \|\| Download paper	27
17	2014	How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers \|\| Download paper	25
18	2009	Cost Effectiveness in Low- and Middle-Income Countries. (2009). Shillcutt, Samuel ; Walker, Damian ; Goodman, Catherine ; Mills, Anne. In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917. Full description at Econpapers \|\| Download paper	25
19	2019	Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Le, Phuc ; Mullen, Patricia Dolan ; Zhang, LU ; Chiyaka, Edward T ; Deshpande, Abhishek ; Nghiem, Van T. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers \|\| Download paper	24
20	2015	The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Rivero-Arias, Oliver ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011. Full description at Econpapers \|\| Download paper	23
21	2017	International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Zouraq, Ismail Azzabi ; Chevrou-Severac, Helene ; Rowen, Donna ; Hout, Ben. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers \|\| Download paper	23
22	2018	German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers \|\| Download paper	22
23	2015	Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers \|\| Download paper	22
24	2018	Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers \|\| Download paper	21
25	2014	Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers \|\| Download paper	21
26	2015	A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers \|\| Download paper	21
27	2014	Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers \|\| Download paper	19
28	2014	The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers \|\| Download paper	19
29	2018	Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Edney, Laura Catherine ; Karnon, Jonathan ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers \|\| Download paper	18
30	2018	A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers \|\| Download paper	18
31	2015	Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers \|\| Download paper	18
32	2011	Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers \|\| Download paper	18
33	2016	Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Verguet, Stephane ; Kim, Jane J ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers \|\| Download paper	17
34	2021	The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Kessler, Ronald C ; Berman, Richard ; Greenberg, Paul E ; Simes, Mark ; Fournier, Andree-Anne ; Sisitsky, Tammy ; Koenigsberg, Sarah H. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers \|\| Download paper	17
35	2018	Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Janssen, Mathieu F ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers \|\| Download paper	17
36	2014	Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Wisloff, Torbjorn ; Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. Full description at Econpapers \|\| Download paper	15
37	2012	Losing Sight of the Wood for the Trees. (2012). Peasgood, Tessa ; Dolan, Paul ; Lee, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers \|\| Download paper	15
38	2015	Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Clement, Fiona ; Godman, Brian ; Elshaug, Adam ; Crausaz, Steffan ; Garner, Sarah ; Pearson, Sallie-Anne ; Lopert, Ruth ; Choudhury, Moni. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers \|\| Download paper	15
39	2010	Using Conjoint Analysis and Choice Experiments to Estimate QALY Values. (2010). Flynn, Terry. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:9:p:711-722. Full description at Econpapers \|\| Download paper	15
40	2017	A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Ara, Roberta ; Chevrou-Severac, Helene ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x. Full description at Econpapers \|\| Download paper	15
41	2013	Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers \|\| Download paper	15
42	2012	Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747. Full description at Econpapers \|\| Download paper	15
43	2017	Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Ijzerman, Maarten J ; Koffijberg, Hendrik ; Fenwick, Elisabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers \|\| Download paper	15
44		The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Liu, Gordon ; Xu, Fei. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292. Full description at Econpapers \|\| Download paper	14
45	2007	Rates and Probabilities in Economic Modelling. (2007). Fleurence, Rachael ; Hollenbeak, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:3-6. Full description at Econpapers \|\| Download paper	14
46	2018	Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers \|\| Download paper	14
47	2016	From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y. Full description at Econpapers \|\| Download paper	13
48	2019	Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). James, Lyndon P ; Prosser, Lisa A ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers \|\| Download paper	13
49	2020	Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Ratcliffe, Julie ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7. Full description at Econpapers \|\| Download paper	13
50	2017	The Indonesian EQ-5D-5L Value Set. (2017). , Joke ; Passchier, Jan ; Purba, Fredrick Dermawan ; Iskandarsyah, Aulia ; Fitriana, Titi Sahidah ; Sadarjoen, Sawitri Supardi ; Ramos-Goi, Juan Manuel. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0538-9. Full description at Econpapers \|\| Download paper	13

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited
1	2008	Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers \|\| Download paper	27
2	2019	Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Soekhai, Vikas ; Bekker-Grob, Esther W ; Ellis, Alan R. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers \|\| Download paper	19
3	2014	Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers \|\| Download paper	14
4	2017	Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers \|\| Download paper	14
5	2016	EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Oppe, Mark ; Rand-Hendriksen, Kim ; Ramosgoi, Juan M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers \|\| Download paper	12
6	2016	Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers \|\| Download paper	11
7	2019	Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Le, Phuc ; Mullen, Patricia Dolan ; Zhang, LU ; Chiyaka, Edward T ; Deshpande, Abhishek ; Nghiem, Van T. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers \|\| Download paper	9
8	2013	How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers \|\| Download paper	9
9	2021	The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Kessler, Ronald C ; Berman, Richard ; Greenberg, Paul E ; Simes, Mark ; Fournier, Andree-Anne ; Sisitsky, Tammy ; Koenigsberg, Sarah H. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers \|\| Download paper	8
10	2018	Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers \|\| Download paper	7
11	2020	Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Ratcliffe, Julie ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7. Full description at Econpapers \|\| Download paper	7
12	2021	Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension. (2021). Jiang, Jie ; Wu, Hongyan ; Bai, Gengliang ; Chen, Gang ; Feng, DA ; Wang, Xiaohui ; Xie, Shitong ; Hu, Ming ; Brazier, John E. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:5:d:10.1007_s40273-020-00997-1. Full description at Econpapers \|\| Download paper	7
13	2017	A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Ara, Roberta ; Chevrou-Severac, Helene ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x. Full description at Econpapers \|\| Download paper	6
14	2017	The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Trapero-Bertran, Marta ; Pea-Longobardo, Luz Maria ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers \|\| Download paper	6
15	2014	A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers \|\| Download paper	6
16	2017	International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Zouraq, Ismail Azzabi ; Chevrou-Severac, Helene ; Rowen, Donna ; Hout, Ben. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers \|\| Download paper	5
17	2022	Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures. (2022). Lancsar, Emily ; Devlin, Nancy ; Howell, Martin ; Harrison, Conrad ; Freijser, Louise ; Bailey, Cate ; Howard, Kirsten ; Mulhern, Brendan ; Dalziel, Kim ; Khan, Kamran ; Hayes, Alison ; Ratcliffe, Julie ; Petrou, Stavros ; Kwon, Joseph ; Daher, Shahd ; Craig, Jonathan ; Smith, Sarah ; Wong, Germaine ; Chen, Gang ; Roberts, Nia ; Huynh, Elisabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-022-01135-9. Full description at Econpapers \|\| Download paper	5
18	2021	Valuing SF-6Dv2 in Australia Using an International Protocol. (2021). Norman, Richard ; Brazier, John ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01043-4. Full description at Econpapers \|\| Download paper	5
19	2020	International Valuation Protocol for the EQ-5D-Y-3L. (2020). Shah, Koonal ; Devlin, Nancy ; Rivero-Arias, Oliver ; Oppe, Mark ; Ramos-Goi, Juan M ; Stolk, Elly ; Kreimeier, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00909-3. Full description at Econpapers \|\| Download paper	5
20	2015	The Epidemiology of Obesity: A Big Picture. (2015). Hu, Frank ; Hruby, Adela . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers \|\| Download paper	5
21	2022	The EQ-5D-5L Valuation Study in Egypt. (2022). al Shabasy, Sahar ; Abbassi, Maggie ; Baines, Darrin ; Roudijk, Bram ; Finch, Aureliano ; Farid, Samar. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-021-01100-y. Full description at Econpapers \|\| Download paper	5
22	2020	A French Value Set for the EQ-5D-5L. (2020). Andrade, Luiz ; Oppe, Mark ; Ludwig, Kristina ; Ramos, Juan Manuel ; Pouvourville, Gerard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00876-4. Full description at Econpapers \|\| Download paper	5
23	2015	Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers \|\| Download paper	5
24	2013	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers \|\| Download paper	5
25	2022	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022). Husereau, Don ; Petrou, Stavros ; Staniszewska, Sophie ; Mullins, Daniel C ; Greenberg, Dan ; Pwu, Raoh-Fang ; Carswell, Chris ; Chaiyakunapruk, Nathorn ; Briggs, Andrew H ; Drummond, Michael ; Caulley, Lisa ; Mauskopf, Josephine ; Augustovski, Federico ; Bekker-Grob, Esther ; Loder, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:6:d:10.1007_s40273-021-01112-8. Full description at Econpapers \|\| Download paper	5
26	2022	Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures. (2022). Lancsar, Emily ; Devlin, Nancy ; Roberts, Nia ; Huynh, Elisabeth ; Howell, Martin ; Harrison, Conrad ; Freijser, Louise ; Bailey, Cate ; Howard, Kirsten ; Mulhern, Brendan ; Dalziel, Kim ; Hayes, Alison ; Khan, Kamran ; Ratcliffe, Julie ; Petrou, Stavros ; Kwon, Joseph ; Daher, Shahd ; Craig, Jonathan ; Smith, Sarah ; Wong, Germaine ; Chen, Gang. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-021-01128-0. Full description at Econpapers \|\| Download paper	5
27	2019	Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). James, Lyndon P ; Prosser, Lisa A ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers \|\| Download paper	4
28	2021	Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden. (2021). Ademi, Zanfina ; Ackerman, Ilana N ; Zomer, Ella ; Liew, Danny. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:3:d:10.1007_s40273-020-00999-z. Full description at Econpapers \|\| Download paper	4
29	2018	Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Janssen, Mathieu F ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers \|\| Download paper	4
30	2018	Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review. (2018). Thayer, Winter Maxwell ; Zhou, MO. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0575-4. Full description at Econpapers \|\| Download paper	4
31	2021	The Challenges of Measuring Informal Care Time: A Review of the Literature. (2021). Lau, Yiu-Shing ; Urwin, Sean ; Sutton, Matt ; Grande, Gunn. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01053-2. Full description at Econpapers \|\| Download paper	4
32	2023	The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice. (2023). Brouwer, Werner ; Baal, Pieter ; Versteegh, Matthijs ; Wouterse, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:6:d:10.1007_s40273-023-01265-8. Full description at Econpapers \|\| Download paper	4
33	2023	Modelling the Cost-Effectiveness of Diagnostic Tests. (2023). Snowsill, Tristan. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:4:d:10.1007_s40273-023-01241-2. Full description at Econpapers \|\| Download paper	4
34	2016	Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Verguet, Stephane ; Kim, Jane J ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers \|\| Download paper	4
35	2019	Future Costs in Cost-Effectiveness Analyses: Past, Present, Future. (2019). Brouwer, Werner ; Vries, Linda M. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0749-8. Full description at Econpapers \|\| Download paper	4
36	2019	Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time. (2019). Pike, Jamison ; Grosse, Scott D ; Soelaeman, Rieza ; Tilford, Mick J. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00782-9. Full description at Econpapers \|\| Download paper	3
37	2012	Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747. Full description at Econpapers \|\| Download paper	3
38	2019	The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra. (2019). Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-018-0730-6. Full description at Econpapers \|\| Download paper	3
39	2018	German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers \|\| Download paper	3
40	2019	The Monetary Value of Informal Care: Obtaining Pure Time Valuations Using a Discrete Choice Experiment. (2019). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske J. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-018-0724-4. Full description at Econpapers \|\| Download paper	3
41	2014	Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers \|\| Download paper	3
42	2015	A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers \|\| Download paper	3
43	2017	Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Ijzerman, Maarten J ; Koffijberg, Hendrik ; Fenwick, Elisabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers \|\| Download paper	3
44	2022	Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Pickard, Simon A ; Gu, Ning Yan ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x. Full description at Econpapers \|\| Download paper	3
45	2023	The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia. (2023). Lorgelly, Paula ; Lancsar, Emily ; Ratcliffe, Julie ; Street, Deborah ; Mulhern, Brendan ; Viney, Rosalie ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:4:d:10.1007_s40273-023-01243-0. Full description at Econpapers \|\| Download paper	3
46	2022	Estimating an EQ-5D-Y-3L Value Set for China. (2022). Jing, Mingxia ; Wu, Jing ; Jiang, Jie ; Yang, Zhihao ; Feng, DA ; Fang, YU ; Zheng, Bin ; Yu, Xiao ; Huang, Weidong ; Li, Shunping ; Wang, Pei ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01216-9. Full description at Econpapers \|\| Download paper	3
47	2021	Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment. (2021). Viney, Rosalie ; King, Madeleine ; Kemmler, Georg ; Gamper, Eva ; Holzner, Bernhard ; Finch, Aureliano Paolo ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:9:d:10.1007_s40273-021-01058-x. Full description at Econpapers \|\| Download paper	2
48	2021	Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States. (2021). Xie, Richard Z ; Linthicum, Mark T ; Bright, Jennifer L ; Malik, Erica Defur. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01036-3. Full description at Econpapers \|\| Download paper	2
49	2022	Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review. (2022). Ward, Thomas ; Mujica-Mota, Ruben E ; Medina-Lara, Antonieta ; Spencer, Anne E. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01094-7. Full description at Econpapers \|\| Download paper	2
50	2015	Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Rivero-Arias, Oliver ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991. Full description at Econpapers \|\| Download paper	2

Citing documents used to compute impact factor: 18

Year	Title
2025	Model-based evaluation of the impact of a potential HIV cure on HIV transmission dynamics. (2025). Reiss, Peter ; Sighem, Ard ; Rozhnova, Ganna ; Guzzetta, Giorgio ; Willemsen, Myrthe S ; de Bellis, Alfredo ; Nijhuis, Monique ; Schim, Maarten F. In: Nature Communications. RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58657-x. Full description at Econpapers \|\| Download paper
2025	Modeling cost-effectiveness analysis of treatment sequencing. (2025). Keller, Robin L ; Bai, Jiaru ; del Campo, Cristina. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:99:y:2025:i:c:s003801212500059x. Full description at Econpapers \|\| Download paper
2025	The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries. (2025). Mokri, Hamraz ; Baal, Pieter ; Mlken, Maureen Rutten-Van. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:1:d:10.1007_s10198-024-01690-2. Full description at Econpapers \|\| Download paper
2025	Benefits beyond health in the willingness to pay for a quality-adjusted life-year. (2025). , Pieter ; Vries, Linda M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:4:d:10.1007_s10198-024-01726-7. Full description at Econpapers \|\| Download paper
2025	Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system. (2025). Garcia-Mochon, Leticia ; Fenix-Caballero, Silvia ; Sanchez-Vegas, Adrin ; Alegre, Emilio Jess ; Epstein, David ; de Labry, Antonio Olry. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:1:d:10.1007_s10198-024-01681-3. Full description at Econpapers \|\| Download paper
2025	The Interplay Between Sleep and Safety Outcomes in the Workplace: A Scoping Review and Bibliographic Analysis of the Literature. (2025). Anwer, Shahnawaz ; Naslund, John A ; Nwaogu, Janet Mayowa. In: IJERPH. RePEc:gam:jijerp:v:22:y:2025:i:4:p:533-:d:1625258. Full description at Econpapers \|\| Download paper
2025	Public hesitancy for AI-based detection of neurodegenerative diseases in France. (2025). Ventelou, Bruno ; Blayac, Thierry ; Dubois, Dimitri ; Davin-Casalena, Brengre ; Rafa, Ismal. In: Post-Print. RePEc:hal:journl:hal-05189620. Full description at Econpapers \|\| Download paper
2025	Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19. (2025). Zhou, Wenjing ; Li, Yaqin ; Busschbach, Jan ; Herdman, Michael ; Yang, Zhihao ; Lu, Yanming. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:3:d:10.1007_s10198-024-01710-1. Full description at Econpapers \|\| Download paper
2025	Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review. (2024). De Donder, Philippe ; Bardey, David ; Zaporozhets, Vera. In: TSE Working Papers. RePEc:tse:wpaper:129120. Full description at Econpapers \|\| Download paper
2025	Comparison of four approaches in eliciting health state utilities with SF-6Dv2. (2025). Poder, Thomas G ; Ameri, Hosein. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:4:d:10.1007_s10198-024-01723-w. Full description at Econpapers \|\| Download paper
2025	Price regulation and competition among on-patent anticancer drugs in Italy. (2025). Mancusi, Maria ; Vassallo, Chiara ; Fiorentino, Francesca ; di Costanzo, Alessandra ; Candelora, Laura ; Caimmi, Michele ; Canali, Beatrice. In: Health Policy. RePEc:eee:hepoli:v:157:y:2025:i:c:s0168851025001046. Full description at Econpapers \|\| Download paper
2025	Well-Being in Family Caregivers of Dementia Patients in Romania. (2025). Glavce, Cristiana Susana ; Tatomirescu, Liviu Florian ; Prada, Gabriel-Ioan ; Borosanu, Adriana ; Turcu, Suzana. In: Disabilities. RePEc:gam:jdisab:v:5:y:2025:i:4:p:90-:d:1769081. Full description at Econpapers \|\| Download paper
2025	Public preferences for skin cancer prevention policies: a discrete choice experiment in three European countries. (2025). van Exel, Job ; Boxebeld, Sander ; Mouter, Niek. In: Social Science & Medicine. RePEc:eee:socmed:v:378:y:2025:i:c:s027795362500485x. Full description at Econpapers \|\| Download paper
2025	Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in Wales. (2025). Warburton, Andrew ; John, Gareth ; Porter, Thomas ; Sloan, Rebecca ; Laing, Hamish ; Pearson-Stuttard, Jonathan ; Clifton-Brown, Emma ; Fuente, Graciela Sinz ; Davies, Mark ; Halsby, Kate ; Bale, Catherine ; Chowdhury, Ruhe ; Povey, Gail ; Selby, Jennifer. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:2:d:10.1007_s40273-024-01445-0. Full description at Econpapers \|\| Download paper
2025	A Taxonomy for Assessing Whether HRQoL Value Sets Are Obsolete. (2025). Devlin, Nancy ; Howard, Kirsten ; Oneill, Ciaran ; Pwu, Raoh-Fang ; Knies, Saskia ; Stolk, Elly ; Jonker, Marcel ; Roudijk, Bram ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:5:d:10.1007_s40273-025-01476-1. Full description at Econpapers \|\| Download paper
2025	Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases. (2025). Rencz, Fanni ; Brodszky, Valentin ; Szab, Kos. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:26:y:2025:i:4:d:10.1007_s10198-024-01728-5. Full description at Econpapers \|\| Download paper
2025	Spatio-temporal distribution and socioeconomic inequality of low birthweight rate in China from 1992 to 2021 and its predictions to 2030. (2025). Li, Yingying ; Lei, Lixia. In: PLOS ONE. RePEc:plo:pone00:0310944. Full description at Econpapers \|\| Download paper
2025	Social genetic insurance: A life-cycle perspective. (2025). Schernberg, Hlne. In: Journal of Health Economics. RePEc:eee:jhecon:v:101:y:2025:i:c:s0167629625000281. Full description at Econpapers \|\| Download paper

Recent citations

Recent citations received in 2025

Year	Citing document
2025	Integrating Equity and Productivity in Health Evaluation. (2025). Ãsterdal, Lars Peter ; Moreno-Ternero, Juan ; Hansen, Kristian S. In: Working Papers. RePEc:hhs:cbsnow:2025_009. Full description at Econpapers \|\| Download paper
2025	Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions. (2025). Robotham, Julie ; Hope, William ; Hewitt, Catherine ; Soares, Marta O ; Aluzaite, Kristina ; Woods, Beth. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:23:y:2025:i:5:d:10.1007_s40258-025-00969-6. Full description at Econpapers \|\| Download paper
2025	Reply to Comment on âExamining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuriaâ. (2025). Gallacher, Daniel. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:7:d:10.1007_s40273-025-01499-8. Full description at Econpapers \|\| Download paper
2025	Comment on âExamining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuriaâ. (2025). Woods, Matthew ; Gladwell, Daniel ; Farrar, Benjamin. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:7:d:10.1007_s40273-025-01500-4. Full description at Econpapers \|\| Download paper

Recent citations received in 2024

Year	Citing document
2024	âManaging valuesâ in health economics modelling: Philosophical and practical considerations. (2024). Winsberg, Eric B ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:358:y:2024:i:c:s027795362400710x. Full description at Econpapers \|\| Download paper
2024	An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?. (2024). Kim, Inkyu ; Chen, Clara ; Okorogheye, Gabriel ; Ho, Sophia ; Hatswell, Anthony J ; Taylor, Kurt ; Latimer, Nicholas R ; Bertwistle, David ; Borrill, John. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:12:d:10.1007_s40273-024-01429-0. Full description at Econpapers \|\| Download paper
2024	Meeting the Challenges of Preference-Weighted Health-Related Quality-of-Life Measurement in Children. (2024). Ungar, Wendy J ; Herdman, Michael. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-024-01383-x. Full description at Econpapers \|\| Download paper
2024	Advancing Methods to Measure and Reward Healthcare Innovation. (2024). Xie, Richard ; Chapman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:42:y:2024:i:2:d:10.1007_s40273-024-01408-5. Full description at Econpapers \|\| Download paper

Recent citations received in 2023

Year	Citing document
2023	The Risk of Household Socioeconomic Deprivation Related to Older Long-Term Care Needs: A Qualitative Exploratory Study in Italy and Spain. (2023). Fernandez-Salido, Mirian ; Casanova, Georgia ; Moreno-Castro, Carolina. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:20:p:15031-:d:1262507. Full description at Econpapers \|\| Download paper
2023	Values in Modelling: Video Series Development and Evaluation Survey. (2023). Werker, Greg ; Murphy, David ; Adibi, Amin ; McLean, Alison ; Easterbrook, Adam ; Harvard, Stephanie. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:5:d:10.1007_s40258-023-00820-w. Full description at Econpapers \|\| Download paper
2023	Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework. (2023). Jiao, Boshen. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01303-5. Full description at Econpapers \|\| Download paper
2023	Modelling Spillover Effects on Informal Carers: The Carer QALY Trap. (2023). Guest, Sophie ; Pennington, Becky ; Scheuer, Nicolas ; Shah, Koonal K ; Schirrmacher, Hannah ; Mott, David J ; Skedgel, Chris ; Al-Janabi, Hareth. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01316-0. Full description at Econpapers \|\| Download paper
2023	The Carer QALY Trap and Altruism in Economic Evaluations. (2023). Tilford, Mick J ; Tarlan, Aygul. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:12:d:10.1007_s40273-023-01324-0. Full description at Econpapers \|\| Download paper
2023	Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. (2023). Pearman, Leny ; Caminis, John ; Reginster, Jean-Yves ; Mathew, Jake ; Singer, Andrea J ; Wang, Yamei ; Silverman, Stuart S ; Hiligsmann, Mickael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:7:d:10.1007_s40273-023-01270-x. Full description at Econpapers \|\| Download paper
2023	Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs. (2023). Brouwer, Werner ; Baal, Pieter. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01307-1. Full description at Econpapers \|\| Download paper

Recent citations received in 2022

Year	Citing document
2022	Where do measures of health, social care and wellbeing fit within a wider measurement framework? Implications for the measurement of quality of life and the identification of bolt-ons. (2022). Mulhern, Brendan ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622006761. Full description at Econpapers \|\| Download paper
2022	The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055. Full description at Econpapers \|\| Download paper
2022	Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?. (2022). Mayer, Susanne ; Simon, Judit ; Aszewska, Agata. In: IJERPH. RePEc:gam:jijerp:v:20:y:2022:i:1:p:117-:d:1010970. Full description at Econpapers \|\| Download paper
2022	Challenges and Limitations in Distributional Cost-Effectiveness Analysis: A Systematic Literature Review. (2022). Pavlova, Milena ; Groot, Wim ; Steijger, Dirk ; Chatterjee, Chandrima. In: IJERPH. RePEc:gam:jijerp:v:20:y:2022:i:1:p:505-:d:1017911. Full description at Econpapers \|\| Download paper
2022	Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments. (2022). Roijen, Leona Hakkaart-Van ; Simon, Judit ; Busschbach, Jan ; Sajjad, Ayesha ; Aszewska, Agata. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01194-y. Full description at Econpapers \|\| Download paper
2022	Response to Comment on âAn Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophreniaâ. (2022). Houwing, Natalie ; Piena, Marjanne A ; Waters, Heidi ; Bennison, Craig ; Kraan, Carla W ; Wang, Xiaofeng. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01213-y. Full description at Econpapers \|\| Download paper
2022	An EQ-5D-Y-3L Value Set for Belgium. (2022). Dewilde, Sarah ; Tollenaar, Nafthali H ; Ramos-Goi, Juan M ; Roudijk, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01187-x. Full description at Econpapers \|\| Download paper
2022	Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Ruzsa, Gabor ; Rencz, Fanni ; Finch, Aureliano Paolo ; Bato, Alex ; Yang, Zhihao. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2. Full description at Econpapers \|\| Download paper
2022	Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values. (2022). Fitriana, Titi Sahidah ; Purba, Fredrick Dermawan ; Stolk, Elly ; Roudijk, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01210-1. Full description at Econpapers \|\| Download paper
2022	Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. (2022). Norman, Richard ; Rivero-Arias, Oliver ; Devlin, Nancy J ; Shah, Koonal K ; Mott, David J ; Kreimeier, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01214-x. Full description at Econpapers \|\| Download paper
2022	Estimating an EQ-5D-Y-3L Value Set for China. (2022). Jing, Mingxia ; Wu, Jing ; Jiang, Jie ; Yang, Zhihao ; Feng, DA ; Fang, YU ; Zheng, Bin ; Yu, Xiao ; Huang, Weidong ; Li, Shunping ; Wang, Pei ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01216-9. Full description at Econpapers \|\| Download paper
2022	Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Pickard, Simon A ; Gu, Ning Yan ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x. Full description at Econpapers \|\| Download paper
2022	EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions. (2022). Viney, Rosalie ; Devlin, Nancy ; Stolk, Elly ; Roudijk, Bram. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01226-7. Full description at Econpapers \|\| Download paper
2022	Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China. (2022). Zhang, Yichen ; Guan, Xiaodong ; Shi, Luwen ; Li, Huangqianyu ; Wei, Yuxuan ; Chen, Yixuan ; Guo, Yiran. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01161-7. Full description at Econpapers \|\| Download paper

10 most frequent citing series

#	Series	H	Cites
1	The European Journal of Health Economics / Springer	31	369
2	IJERPH / MDPI	48	222
3	Social Science & Medicine / Elsevier	80	213
4	PharmacoEconomics / Springer	22	117
5	Health Economics / John Wiley & Sons, Ltd.	82	116
6	PLOS ONE / Public Library of Science	59	101
7	Health Policy / Elsevier	39	76
8	Journal of choice modelling / Elsevier	22	27
9	Applied Health Economics and Health Policy / Springer	16	20
10	Sustainability / MDPI	75	18
11	LSE Research Online Documents on Economics / London School of Economics and Political Science, LSE Library	139	16